HUP9701277A2 - Eljárás parathiroid hormon és parathiroid hormonnal rokon peptidek analógjainak szintézisére - Google Patents

Eljárás parathiroid hormon és parathiroid hormonnal rokon peptidek analógjainak szintézisére

Info

Publication number
HUP9701277A2
HUP9701277A2 HU9701277A HUP9701277A HUP9701277A2 HU P9701277 A2 HUP9701277 A2 HU P9701277A2 HU 9701277 A HU9701277 A HU 9701277A HU P9701277 A HUP9701277 A HU P9701277A HU P9701277 A2 HUP9701277 A2 HU P9701277A2
Authority
HU
Hungary
Prior art keywords
hormone
parathiroide
peptides connected
producing analogous
analogous
Prior art date
Application number
HU9701277A
Other languages
English (en)
Inventor
Humberto Arzeno
Original Assignee
F.Hoffmann-La Roche Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag. filed Critical F.Hoffmann-La Roche Ag.
Publication of HU9701277D0 publication Critical patent/HU9701277D0/hu
Publication of HUP9701277A2 publication Critical patent/HUP9701277A2/hu
Publication of HUP9701277A3 publication Critical patent/HUP9701277A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C07K1/026—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

A találmány fragmens kőndenzációs eljárás őlyan parathirőid hőrmőn(PTH) és parathirőid hőrmőnnal rőkőn peptid (PTHrP) analógőkelőállítására, amelyekben a (22-31) aminősav maradék szintetikűsamfipatikűs a-hélixet képez. ŕ
HU9701277A 1996-07-30 1997-07-23 Process for producing analogous of parathiroide hormone and peptides connected with parathiroide hormone HUP9701277A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2332296P 1996-07-30 1996-07-30

Publications (3)

Publication Number Publication Date
HU9701277D0 HU9701277D0 (en) 1997-09-29
HUP9701277A2 true HUP9701277A2 (hu) 1998-11-30
HUP9701277A3 HUP9701277A3 (en) 2001-02-28

Family

ID=21814418

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9701277A HUP9701277A3 (en) 1996-07-30 1997-07-23 Process for producing analogous of parathiroide hormone and peptides connected with parathiroide hormone

Country Status (30)

Country Link
US (1) US6849710B1 (hu)
EP (1) EP0822200B1 (hu)
JP (1) JP4229992B2 (hu)
KR (1) KR100518982B1 (hu)
CN (1) CN1293096C (hu)
AR (2) AR008094A1 (hu)
AT (1) ATE277080T1 (hu)
AU (1) AU731160B2 (hu)
BR (1) BR9704138A (hu)
CA (1) CA2206008C (hu)
CO (1) CO4650046A1 (hu)
CZ (1) CZ239697A3 (hu)
DE (1) DE69730787T2 (hu)
DK (1) DK0822200T3 (hu)
ES (1) ES2227639T3 (hu)
HR (1) HRP970416A2 (hu)
HU (1) HUP9701277A3 (hu)
IL (1) IL121391A0 (hu)
MA (1) MA24353A1 (hu)
MX (1) MX9705719A (hu)
NO (1) NO973482L (hu)
NZ (1) NZ328411A (hu)
PE (1) PE91998A1 (hu)
PL (1) PL321391A1 (hu)
SG (1) SG67408A1 (hu)
TR (1) TR199700714A2 (hu)
TW (1) TW505654B (hu)
UY (1) UY24651A1 (hu)
YU (1) YU32197A (hu)
ZA (1) ZA976555B (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04006728A (es) * 2002-01-10 2005-08-19 Osteotrophin Llc Tratamiento de desordenes oseos con medicamentos anabolicos esqueleticos.
US7378495B2 (en) * 2002-10-21 2008-05-27 Pevion Biotech, Ltd. PTH-rP related peptide cancer therapeutics
CA2628945A1 (en) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US20090093016A1 (en) * 2006-01-17 2009-04-09 N.V. Organon Selective Enzymatic Hydrolysis of C-Terminal Tert-Butyl Esters of Peptides
US7803770B2 (en) * 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
SI2957278T1 (sl) 2006-10-03 2017-09-29 Radius Health, Inc. Stabilni sestavek, ki obsega PTHrP, in njegova uporaba
CN102448482A (zh) 2009-03-27 2012-05-09 范安德尔研究所 甲状旁腺素肽和甲状旁腺素相关蛋白肽及使用方法
WO2011071480A1 (en) 2009-12-07 2011-06-16 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
CN102731643A (zh) * 2012-06-26 2012-10-17 深圳翰宇药业股份有限公司 一种治疗骨质疏松多肽的制备方法
CN102993293B (zh) * 2012-12-05 2014-05-07 深圳翰宇药业股份有限公司 一种特立帕肽醋酸盐的纯化方法
WO2014147129A1 (en) 2013-03-21 2014-09-25 Sanofi-Aventis Deutschland Gmbh Synthesis of cyclic imide containing peptide products
EP2976331B1 (en) 2013-03-21 2017-03-01 Sanofi-Aventis Deutschland GmbH Synthesis of hydantoin containing peptide products
CN104530198B (zh) * 2014-12-09 2017-09-15 兰州大学 一种片段缩合制备醋酸去氨加压素的方法
EP4039253A1 (en) 2015-04-29 2022-08-10 Radius Pharmaceuticals, Inc. Methods of treating cancer
KR20230109795A (ko) 2017-01-05 2023-07-20 래디어스 파마슈티컬스, 인코포레이티드 Rad1901-2hcl의 다형 형태
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
EP3765488A1 (en) * 2018-03-12 2021-01-20 Fresenius Kabi iPSUM S.r.l. Process for the manufacture of pthrp analogue
JP7473486B2 (ja) 2018-07-04 2024-04-23 ラジウス ファーマシューティカルズ，インコーポレイテッド Ｒａｄ１９０１－２ｈｃｌの多形形態
CN111057139B (zh) * 2018-10-17 2023-12-22 南京华威医药科技集团有限公司 一种制备特立帕肽的新工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886132A (en) * 1972-12-21 1975-05-27 Us Health Human parathyroid hormone
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
AU667662B2 (en) * 1990-07-13 1996-04-04 Regents Of The University Of California, The Parathyroid hormone analogues modified at positions 3, 6 or 9
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
CN1070500C (zh) * 1993-07-13 2001-09-05 森德克斯(美国)股份有限公司 甲状旁腺激素类似物和甲状旁腺激素相关肽：合成和治疗骨质疏松症的用途
CO4410206A1 (es) * 1994-07-28 1997-01-09 Sandoz Ag DERIVADOS DE PTH o PTHrP, SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN

Also Published As

Publication number Publication date
HRP970416A2 (en) 1998-08-31
HU9701277D0 (en) 1997-09-29
NO973482D0 (no) 1997-07-29
DK0822200T3 (da) 2005-01-31
UY24651A1 (es) 2000-12-29
MA24353A1 (fr) 1998-07-01
PL321391A1 (en) 1998-02-02
ZA976555B (en) 1998-01-30
CZ239697A3 (cs) 1998-04-15
TW505654B (en) 2002-10-11
CA2206008A1 (en) 1998-01-30
KR980009282A (ko) 1998-04-30
JP4229992B2 (ja) 2009-02-25
DE69730787T2 (de) 2005-10-13
BR9704138A (pt) 1998-12-29
TR199700714A2 (xx) 1998-02-21
MX9705719A (es) 1998-02-28
CO4650046A1 (es) 1998-09-03
HUP9701277A3 (en) 2001-02-28
PE91998A1 (es) 1998-12-31
CN1293096C (zh) 2007-01-03
NZ328411A (en) 1998-12-23
EP0822200A1 (en) 1998-02-04
AR016981A2 (es) 2001-08-01
JPH1077295A (ja) 1998-03-24
ES2227639T3 (es) 2005-04-01
CN1174845A (zh) 1998-03-04
ATE277080T1 (de) 2004-10-15
EP0822200B1 (en) 2004-09-22
KR100518982B1 (ko) 2006-05-29
US6849710B1 (en) 2005-02-01
IL121391A0 (en) 1998-01-04
NO973482L (no) 1998-02-02
SG67408A1 (en) 1999-09-21
CA2206008C (en) 2008-09-23
AU731160B2 (en) 2001-03-22
YU32197A (sh) 1999-07-28
AU3236297A (en) 1998-02-05
AR008094A1 (es) 1999-12-09
DE69730787D1 (de) 2004-10-28

Similar Documents

Publication Publication Date Title
HUP9701277A2 (hu) Eljárás parathiroid hormon és parathiroid hormonnal rokon peptidek analógjainak szintézisére
DE69739912D1 (de) Parathyroidhormon Analoge
ATE202115T1 (de) Pth und pthrp analoge deren herstellung und verwendung für die behandlung von osteoporosis.
HUP0101629A2 (en) Process for the preparation of resin-bound cyclic peptides
DE69638025D1 (de) Parathyroidhormon Analoge
NZ527053A (en) Modified amyloid precursor protein polynucleotides and polypeptides
ZA885764B (en) Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology,process,expression vector and recombinant host therefor and pharmaceutical use thereof
AU6251596A (en) Method for the treatment of corticosteroid induced osteopeni a
MXPA04000597A (es) Peptidos novedosos de la proteina g del virus sincicial respiratorio (rsv), y su uso en una vacuna.
AU1003888A (en) Pancreatic secretory trypsin inhibitor and variants thereof produced by a recombinant host, process, expression vector and recombinant host therefore and pharmaceutical use thereof
SE8204811D0 (sv) Dna fragment comprising a signal sequence
NZ592340A (en) A method for making a virus vaccine compising Replikin peptides
MX167236B (es) Peptidos sinteticos de timosina -1 y metodo para su obtencion
ES2072422T3 (es) Procedimiento para la produccion de peptidos amidados en alfa en el terminal c.
NO20012232L (no) Enzymatisk amidering av peptider
DE69623803T2 (de) Verwendung von KASEINFRAGMENTEn als WACHSTUMERFÖRDERer
EP0305063A3 (en) A process for production of c-terminal alpha-amide peptides
Stevenson et al. Identification and quantitation of tetrapeptide deamidation products by mass spectrometry
ATE283914T1 (de) Iga1-protease fragment als trägerpeptid
TH13841A (th) คิดไทโอสตีเลียม ไดเพพทิดิลอะมิโนเพพทิเดส